Remove nation special-reports coronavirus
article thumbnail

New findings on 171 hot and emerging Research Fronts

Clarivate

The 2021 report, like its predecessor, bases its findings on Research Fronts, which are self-organizing clusters of related research identified by citation analysis. A unique advantage of Research Fronts is that identifying these ‘nodes’ of specialized activity does not depend on the judgements of human indexers or analysts.

article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

The negotiations over the treaty are being hosted through the World Health Organization (WHO), with plans to officially adopt a binding agreement sealed by the United Nations health agency’s member countries in May 2024. The UN Special Rapporteur on contemporary forms of racism, E.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Improving COVID Care Delays: How Pharma Companies Can Help Patients

PM360

alone—but it hit pause on an industry used to providing in-person medical care, specialized surgical procedures, and routine health screenings to hundreds of millions of people annually. Chan School of Public Health, the Robert Wood Johnson Foundation, and National Public Radio, found that roughly 20% of U.S. References: 1.

article thumbnail

Updates on Salesforce Safety and Wellbeing Actions

Salesforce

And while the long term effects of COVID-19 on unemployment remain to be seen, we know our nation’s veteran community is experiencing immediate impact at unprecedented rates. ‘s National Health System (NHS). A recent internal survey showed that 36% are reporting mental health issues during this stressful time.

Safety 52
article thumbnail

Sorry.COVID treatment data may not be reliable

World of DTC Marketing

s commissioner, went so far as to suggest that the plasma therapy could save the lives of 35 out of every 100 coronavirus patients who took it. million to broader political groups like the Moderate Democrats PAC or the National Republican Senatorial Committee, and to other drug industry PACs, including PhRMA’s.